BRKR (BRKR) Stock Analysis

Verdict: HOLD

Goodwill impairments mask underlying 5.2% organic growth, but high debt and insider selling suggest the post-crash floor isn't yet firm.

Investment score: 48/100

The AI model recommends a HOLD. While the 20% haircut reflects a significant goodwill impairment, the underlying 36% revenue growth and 46.7% gross margins remain intact. However, the valuation (68x EV/EBITDA) is still expensive relative to BIO (149x) and RGEN (70x) when adjusted for Bruker's significantly higher leverage.

Peers

PeerP/EP/BP/SEV/EBITDAROIC %Net margin %
CRL-48.274.002.82-489.07-0.06
AVTR-16.311.641.41455.98-0.09
BIO39.941.243.47149.220.09
TEM-32.9019.035.76-99.97-0.18
RGEN202.414.0010.7770.070.05

View the full interactive analysis